Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
195 hedge funds and large institutions have $2.15B invested in Kite Pharma, Inc. in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 82 increasing their positions, 42 reducing their positions, and 19 closing their positions.
126% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 19
95% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 42
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
14% more capital invested
Capital invested by funds: $1.88B → $2.15B (+$267M)
13% more funds holding
Funds holding: 173 → 195 (+22)
23% less call options, than puts
Call options by funds: $68.3M | Put options by funds: $88.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$39.9M |
| 2 |
BII
Bainco International Investors
Boston,
Massachusetts
|
+$36.1M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$32.8M |
| 4 |
HCM
Highline Capital Management
New York
|
+$28.2M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$26.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$112M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$58.7M |
| 3 |
JP Morgan Chase
New York
|
-$31.2M |
| 4 |
RI
RTW Investments
New York
|
-$14.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.45M |
KITE Hedge Fund Activity: Q3 2016 in Review
195 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q3 2016, worth a combined $2.15B — up 14% from $1.88B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new KITE positions and 19 closed out — a net gain of 24 holders — while 82 added to existing stakes and 42 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $39.9M. The largest seller was Viking Global Investors, cutting an estimated $112M.
- 195 institutional investors held Kite Pharma, Inc. (KITE) as of Q3 2016, up from 173 in Q2 2016.
- Funds reported $2.15B of Kite Pharma, Inc. stock for Q3 2016, up 14% quarter-over-quarter.
- 43 funds opened new Kite Pharma, Inc. positions in Q3 2016 and 19 closed out, a net change of +24 holders.
- The largest Kite Pharma, Inc. buyer in Q3 2016 was Waddell & Reed Financial, an estimated $39.9M added.
- The largest Kite Pharma, Inc. seller in Q3 2016 was Viking Global Investors, an estimated $112M sold.
Based on aggregated 13F filings for Q3 2016.